Interleukin-6 in Migraine

Interleukin-6 is a other marker reported as elevated in Migraine when patients are compared with headache-free controls. The source does not tie this marker to a specific symptom cluster, so it is best read as a biological signal rather than a symptom predictor. The finding is drawn from Empl et al. 2003; it describes group-level differences, not a threshold that classifies an individual.

↑ ElevatedOther

Summary

Direction in Migraine↑ Elevated — higher than in the comparison group
CategoryOther
Compared againstheadache-free controls
SourceEmpl et al. 2003 — doi:10.1046/j.1468-2982.2003.00453.x
Condition atlasMigraine Biomarker Atlas

Other conditions where Interleukin-6 (IL-6) is reported

See the cross-condition hub: Interleukin-6 (IL-6) across conditions.

Related Other markers in Migraine

Full list: Migraine Biomarker Atlas.

Frequently asked questions

Is Interleukin-6 high or low in Migraine?

Elevated. Studies summarised in the OSMF atlas report higher Interleukin-6 in Migraine than in headache-free controls. Source: Empl et al. 2003.

Which test measures Interleukin-6?

The atlas record does not list a standardised clinical test code (LOINC) for Interleukin-6, which usually means it was measured with research assays or study-specific protocols rather than a routine clinical panel. Check the cited source for the exact method.

Is one abnormal Interleukin-6 result diagnostic of Migraine?

No. No single biomarker is diagnostic of Migraine. Interleukin-6 findings come from group comparisons, overlap considerably between patients and controls, and vary with study design, timing and comparison group. A result should be interpreted by a clinician alongside symptoms, history and other tests.

Is Interleukin-6 specific to Migraine?

No. The same marker is also reported in Atrial Fibrillation, Epilepsy, Gulf War Illness, Long COVID, Low Back Pain, Lyme Disease, ME/CFS, Major Depressive Disorder, PACVS, Rheumatoid Arthritis in this atlas, so it reflects shared biology (for example inflammation or vascular stress) rather than a condition-specific signature.

Cite this page

Open Source Medicine Foundation. (2026). Interleukin-6 in Migraine: direction, evidence and what it means. OSMF Research Tracker. Retrieved October 8, 2026, from https://research.opensourcemed.info/biomarkers/migraine/interleukin-6.html
Get OSMF research updates. New biomarker, trial and treatment evidence summaries by email.
Subscribe on Substack

Last reviewed: 2026-10-08 · Page generated from migraine.json · Browse: Migraine atlas · Biomarker Index · All marker pages

Disclaimer: This page is an educational synthesis of published, peer-reviewed research and is not medical advice. Biomarker findings vary across studies with case definitions, comparison groups, timing and assay methods. Direction of change reflects the predominant finding in the cited source and does not establish a diagnostic threshold. Discuss any test result with a qualified clinician.